Tiptree (TIPT) Q2 2026 earnings summary

Executive summary

• Completed the sale of Fortegra for $1.65 billion, generating $1.12 billion in gross proceeds and an after-tax gain of $372.2 million, and sold Reliance for $49.7 million, resulting in a strategic shift to a single operating segment.

• Net income for the quarter was $389.2 million, driven by the gain on sale of Fortegra, compared to $19.0 million in the prior year.

• Entered into a definitive agreement to acquire Universal Shield Insurance Group (USIG) for $100 million, re-establishing a specialty insurance platform.

• Repurchased $10.3 million of common stock in the first half of 2026 at an average price of $16.80 per share.

• Book value per share increased 82.6% year-over-year to $24.34 as of June 30, 2026.

Financial highlights

• Book value per share increased to $24.34 as of June 30, 2026, up from $13.33 a year earlier.

• Net income from continuing operations was a loss of $6.4 million for the quarter, improved from a $10.4 million loss in the prior year.

• Net income from discontinued operations was $395.7 million for the quarter, up from $29.4 million in the prior year, primarily due to the Fortegra sale.

• Total stockholders' equity rose to $907.1 million as of June 30, 2026, from $752.4 million at year-end 2025.

• Cash and cash equivalents increased to $946.9 million, up from $30.8 million at year-end 2025, reflecting sale proceeds.

Outlook and guidance

• Management expects current liquidity and investment portfolio to support growth, capital expenditures, and general corporate needs for several years.

• Acquisition of USIG expected to close in Q1 2027, subject to regulatory approvals, aiming to accelerate growth and expand specialty insurance capabilities.